BETRF BETTERLIFE PHARMA INC

Short Interest in BetterLife Pharma Inc. (OTCMKTS:BETRF) Declines By 20.5%

BetterLife Pharma Inc. (OTCMKTS:BETRF – Get Rating) saw a large drop in short interest in the month of July. As of July 15th, there was short interest totalling 57,100 shares, a drop of 20.5% from t

08-04 16:11

BetterLife Pharma Inc. (OTCMKTS:BETRF) Short Interest Update

BetterLife Pharma Inc. (OTCMKTS:BETRF – Get Rating) was the recipient of a large drop in short interest during the month of July. As of July 15th, there was short interest totalling 57,100 shares, a

08-02 19:02

BetterLife's Preclinical Studies Of BETR-001 For Depression Gets Additional Sponsorship By Mitacs

Biotech psychedelics company BetterLife Pharma Inc. (OTCQB:BETRF) in collaboration with the Carleton University Dept. of Neuroscience has received funding from the Mitacs Accelerate Program for resear

07-07 02:00

BetterLife Secures Additional Mitacs Funding in Collaboration with Carleton University Research Team for BETR-001 Preclinical Depression Studies

VANCOUVER, British Columbia, July 06, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE:BETR, OTCQB:BETRF), an emerging biotech company focused on the development and commercialization of cutting-edge treatments for m

07-06 20:05

BetterLife To Participate at the H.C. Wainwright 1st Annual Mental Health Conference

VANCOUVER, British Columbia, June 23, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on t

06-23 20:05

BetterLife To Present BETR-001 Preclinical Data at the Upcoming Federation of European Neuroscience Societies (FENS) Forum

VANCOUVER, British Columbia, June 21, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE:BETR, OTCQB:BETRF), an emerging biotech company focused on the development and commercialization of cutting-edge treatments for m

06-21 20:06

BetterLife To Present BETR-001 Preclinical Data at the Upcoming Canadian Association for Neuroscience Conference

VANCOUVER, British Columbia, April 21, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on

04-21 20:08

BetterLife’s BETR-001 Demonstrates BETR-001 Anti-depressant Activity in Preclinical Models of Depression

VANCOUVER, British Columbia, April 06, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on

04-06 20:10

BetterLife Lead Drug (BETR-001) Promotes Structural Neural Plasticity in Preclinical Model

VANCOUVER, British Columbia, Feb. 15, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on t

02-15 21:08

BetterLife Launches New Corporate Website

VANCOUVER, British Columbia, Feb. 10, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR/ OTCQB: BETRF/ FRA: NPAU), an emerging biotech company focused on the

02-10 21:11